India Russia city Pune city Moscow, Russia virus vaccine India Russia city Pune city Moscow, Russia

Serum Institute gets DCGI's nod to manufacture Covid vaccine Sputnik V in India: Report

Reading now: 730
www.livemint.com

PTI.The Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility, the report added.

The company had submitted an application to the DCGI in this regard on Thursday. According to the four conditions set by the DCGI, the Serum Institute will have to submit a copy of the agreement between it and the Gamaleya Research Institute of Epidemiology and Microbiology for transfer of cell bank and virus stock and submit the copy of agreement for technology transfer with Gamaleya.Further, the SII has to submit a copy of the RCGM permission to import cell bank and virus stock and a copy of the RCGM permission to initiate research and.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA